Global Autoimmune Treatment Market

1
MarketsandMarkets Presents
Global Autoimmune Treatment Market Worth US68.81
Billion by 2014
http//www.marketsandmarkets.com/Market-Reports/au
toimmune-treatment-market-research-27.html
2
According to a new market research report,
Global Autoimmune Treatment Market (20092014),
published by MarketsandMarkets , the market is
expected to be worth US68.81 billion by 2014,
with an estimated CAGR of 12.7 from 2009 to
2014. The North American market is expected to
account for nearly 42 of the total
revenues. Browse 100 market data tables and
in-depth TOC on autoimmune treatment market.
http//www.marketsandmarkets.com/Market-Reports/a
utoimmune-treatment-market-research-27.html Early
buyers will receive 10 customization of
reports
3
Autoimmune disorders result from an overactive
immune response of a body working against its own
cells. The disease is broadly classified into two
types systemic autoimmune diseases, which affect
several organs of the body and localized
autoimmune diseases, which affect only one organ.
Around 80 autoimmune diseases are recognized
under these two categories. The disease affected
over 300 million people across the globe in 2009.
No defined reasons have been discovered to date
for the occurrence of the disorder. Women are
more prone to autoimmune diseases, constituting
70-75 of all autoimmune patients.  The global
market for autoimmune disease treatments is
estimated to be at 37.84 billion in 2009 and is
growing at a CAGR of 12.7 from 2009 to 2014. The
market is forecasted to be at 68.81 billion in
2014. The effects of the global meltdown are
given careful consideration when forecasting the
market. As autoimmune disorders still have no
permanent cure, more and more pharmaceutical
companies are making significant RD investments
into finding treatments for autoimmune diseases,
are also focusing on finding the causes behind
the disease, which again are unknown.
4
The overall market for the treatment of
autoimmune disorders is analyzed into the
submarkets for applications, products, services,
and technologies. The application market is
further classified into the treatment markets for
systemic autoimmune diseases and localized
autoimmune diseases. The applications market is
dominated mostly by rheumatoid arthritis under
the systemic disease segment, while multiple
sclerosis is the major application market under
the localized disease segment. These two
disorders  account for 75 of the total
applications market. The other major diseases
analysed under the application market are
psoriasis, lupus, type I diabetes, inflammatory
bowel disease, and thyroid disorders, which
together account for 15-20 of the global
applications market. The product market is
classified on the basis of the drugs, diagnostic
equipments, therapeutic and monitoring equipment.
Drugs form the largest segment of the products
market, with major drugs such as NSAID, DMARD,
biologic DMARD, Avonex, Rebif, Copaxone,
Betaseron, and 5-ASA. The services market
consists of consultation and diagnosis, therapy
and monitoring, and drug development. The wide
and increasing prevalence of autoimmune diseases
is boosting the drugs market along with the
therapy and monitoring market along with the
fact that almost all autoimmune diseases are
chronic and have no permanent cure.
5
Scope of the Report The report provides market
overviews, market forecasts, market drivers and
restraints for the autoimmune treatment market.
In addition, the report profiles the top forty
market players and their respective autoimmune
products. The report identifies and analyzes the
market according to application markets for both
systemic and localized autoimmune diseases,
product markets, services market, and
technologies market.  Autoimmune Treatment
Applications Systemic autoimmune diseases
rheumatoid arthritis, psoriasis, lupus and other
systemic autoimmune diseases. Localized
autoimmune diseases multiple sclerosis,
inflammatory bowel disease, diabetes, thyroid and
other localized autoimmune diseases. Autoimmune
Treatment Products Drugs, diagnostic
equipments, therapeutic and monitoring equipments
and other products. Autoimmune Treatment
Services Consultation Diagnosis, Therapy
Monitoring, Drug Development and other services.
6
Autoimmune Treatment Technologies DMARD
(disease-modifying anti-rheumatic drugs) and
biologic DMARD therapy, Bridge therapy, Topical
therapy, Phototherapy, Helminthic therapy, Fecal
bacteriotherapy, Haematopoietic stem-cell
transplantation, Recombinant technology
7
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/au
toimmune-treatment-market-research-27.html
8
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Bloghttp//twitter.com/market
smarkets
http//www.linkedin.com/company/marketsandmarkets